– Transaction improves Vireo’s cash position and reduces operating losses – – Company maintains expectation to become cash flow positive in fiscal 2021– MINNEAPOLIS – October 1, 2020 – Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO, OTCQX: VREOF), the science-focused, multi-state cannabis company with active operations in exclusively medical-only markets and licenses in seven states and the Commonwealth of Puerto Rico, today announced that it has reached a definitive agreement with Ayr Strategies Inc. (CSE:AYR.A)(OTCQX:AYRSF), to sell...
Read more
Vireo Health Announces Sale of Assets of Ohio Medical Solutions to Ayr Strategies for Total Consideration of $4.85 Million
Vireo’s Science Team Publishes Peer-Reviewed Article in the Journal of Cannabis Research
Vireo is proud to announce that for the first time in our company’s history, we have published a peer-reviewed research paper in a scientific journal, the Journal of Cannabis Research....
Read more
Free Expungement Clinic Offered in Capitol Heights to Help Clear Cannabis Convictions from Criminal Records
Mary & Main to partner with Minorities for Medical Marijuana and Vireo Health to host free expungement event with Prince George’s County State’s Attorney Aisha Braveboy and Maryland State Delegate...
Read more
Vireo Health Announces Second Quarter 2020 Financial Results
– Total revenue of $12.2 million increased 70 percent year-over-year – – Operating cost structure continues to improve in-line with management’s expectations – – Development project pipeline positions Company for...
Read more
Vireo Health Completes Sale of Equity in Pennsylvania Medical Solutions to Jushi Holdings Inc. for Total Consideration of $37 Million
- Transaction secures Vireo's financial future without dilutive impacts to shareholders - - Vireo to reinvest a portion of the proceeds to increase scale in key markets - - Completed...
Read more View More >